IL6 and diabetes mellitus: In turn, these activate tumour necrosis factor-alpha (TNFα) and interleukin-6 (IL6), both of which exhibit increased serum levels with age and disease and mediate inflammation/fibrosis in multiple secondary complications of diabetes [67,68,69,70,71].